178 related articles for article (PubMed ID: 33806689)
1. Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort.
Gázquez A; Giménez-Bañón MJ; Prieto-Sánchez MT; Martínez-Graciá C; Suárez C; Santaella-Pascual M; Galdo-Castiñeira L; Ballesteros-Meseguer C; Vioque J; Martínez-Villanueva M; Avilés-Plaza F; Noguera-Velasco JA; Morales E; García-Marcos L; Larqué E; On Behalf Of The Nela Study Group
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33806689
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of docosahexaenoic acid-enriched formula to enhance maternal and fetal blood docosahexaenoic acid levels: Randomized double-blinded placebo-controlled trial of pregnant women with gestational diabetes mellitus.
Min Y; Djahanbakhch O; Hutchinson J; Eram S; Bhullar AS; Namugere I; Ghebremeskel K
Clin Nutr; 2016 Jun; 35(3):608-14. PubMed ID: 26091965
[TBL] [Abstract][Full Text] [Related]
3. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes.
Prieto-Sánchez MT; Ruiz-Palacios M; Blanco-Carnero JE; Pagan A; Hellmuth C; Uhl O; Peissner W; Ruiz-Alcaraz AJ; Parrilla JJ; Koletzko B; Larqué E
Clin Nutr; 2017 Apr; 36(2):513-521. PubMed ID: 26869380
[TBL] [Abstract][Full Text] [Related]
4. Child Head Circumference and Placental MFSD2a Expression Are Associated to the Level of MFSD2a in Maternal Blood During Pregnancy.
Sánchez-Campillo M; Ruiz-Palacios M; Ruiz-Alcaraz AJ; Prieto-Sánchez MT; Blanco-Carnero JE; Zornoza M; Ruiz-Pastor MJ; Demmelmair H; Sánchez-Solís M; Koletzko B; Larqué E
Front Endocrinol (Lausanne); 2020; 11():38. PubMed ID: 32117064
[TBL] [Abstract][Full Text] [Related]
5. Placental fatty acid transfer: a key factor in fetal growth.
Larqué E; Pagán A; Prieto MT; Blanco JE; Gil-Sánchez A; Zornoza-Moreno M; Ruiz-Palacios M; Gázquez A; Demmelmair H; Parrilla JJ; Koletzko B
Ann Nutr Metab; 2014; 64(3-4):247-53. PubMed ID: 25300267
[TBL] [Abstract][Full Text] [Related]
6. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy.
Malcolm CA; Hamilton R; McCulloch DL; Montgomery C; Weaver LT
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3685-91. PubMed ID: 12882824
[TBL] [Abstract][Full Text] [Related]
7. Pregnant women with gestational diabetes and with well controlled glucose levels have decreased concentrations of individual fatty acids in maternal and cord serum.
Ortega-Senovilla H; Schaefer-Graf U; Herrera E
Diabetologia; 2020 Apr; 63(4):864-874. PubMed ID: 31832744
[TBL] [Abstract][Full Text] [Related]
8. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
[TBL] [Abstract][Full Text] [Related]
9. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus.
Pagán A; Prieto-Sánchez MT; Blanco-Carnero JE; Gil-Sánchez A; Parrilla JJ; Demmelmair H; Koletzko B; Larqué E
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E826-33. PubMed ID: 23921142
[TBL] [Abstract][Full Text] [Related]
10. The effects of a combined intervention (docosahexaenoic acid supplementation and home-based dietary counseling) on metabolic control in obese and overweight pregnant women: the MIGHT study.
Garmendia ML; Casanello P; Flores M; Kusanovic JP; Uauy R
Am J Obstet Gynecol; 2021 May; 224(5):526.e1-526.e25. PubMed ID: 33152314
[TBL] [Abstract][Full Text] [Related]
11. Maternal plasma phospholipid polyunsaturated fatty acids in pregnancy with and without gestational diabetes mellitus: relations with maternal factors.
Wijendran V; Bendel RB; Couch SC; Philipson EH; Thomsen K; Zhang X; Lammi-Keefe CJ
Am J Clin Nutr; 1999 Jul; 70(1):53-61. PubMed ID: 10393139
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness on maternal and offspring metabolic control of a home-based dietary counseling intervention and DHA supplementation in obese/overweight pregnant women (MIGHT study): A randomized controlled trial-Study protocol.
Garmendia ML; Corvalán C; Casanello P; Araya M; Flores M; Bravo A; Kusanovic JP; Olmos P; Uauy R
Contemp Clin Trials; 2018 Jul; 70():35-40. PubMed ID: 29777864
[TBL] [Abstract][Full Text] [Related]
13. Maternal overweight is not an independent risk factor for increased birth weight, leptin and insulin in newborns of gestational diabetic women: observations from the prospective 'EaCH' cohort study.
Ott R; Stupin JH; Loui A; Eilers E; Melchior K; Rancourt RC; Schellong K; Ziska T; Dudenhausen JW; Henrich W; Plagemann A
BMC Pregnancy Childbirth; 2018 Jun; 18(1):250. PubMed ID: 29925339
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women.
Lager S; Ramirez VI; Acosta O; Meireles C; Miller E; Gaccioli F; Rosario FJ; Gelfond JAL; Hakala K; Weintraub ST; Krummel DA; Powell TL
J Clin Endocrinol Metab; 2017 Dec; 102(12):4557-4567. PubMed ID: 29053802
[TBL] [Abstract][Full Text] [Related]
15. Altered materno-fetal transfer of 13C-polyunsaturated fatty acids in obese pregnant women.
Gázquez A; Prieto-Sánchez MT; Blanco-Carnero JE; Ruíz-Palacios M; Nieto A; van Harskamp D; Oosterink JE; Schierbeek H; van Goudoever JB; Demmelmair H; Koletzko B; Larqué E
Clin Nutr; 2020 Apr; 39(4):1101-1107. PubMed ID: 31029479
[TBL] [Abstract][Full Text] [Related]
16. Obese Nondiabetic Pregnancies and High Maternal Glycated Hemoglobin at Delivery as an Indicator of Offspring and Maternal Postpartum Risks: The Prospective PEACHES Mother-Child Cohort.
Ensenauer R; Brandlhuber L; Burgmann M; Sobotzki C; Zwafink C; Anzill S; Holdt L; Teupser D; Hasbargen U; Netz H; Roscher AA; von Kries R
Clin Chem; 2015 Nov; 61(11):1381-90. PubMed ID: 26265704
[TBL] [Abstract][Full Text] [Related]
17. Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
Zhao JP; Levy E; Fraser WD; Julien P; Delvin E; Montoudis A; Spahis S; Garofalo C; Nuyt AM; Luo ZC
PLoS One; 2014; 9(1):e85054. PubMed ID: 24454790
[TBL] [Abstract][Full Text] [Related]
18. Diabetic pregnancy, maternal and fetal docosahexaenoic acid: a review of existing evidence.
Léveillé P; Rouxel C; Plourde M
J Matern Fetal Neonatal Med; 2018 May; 31(10):1358-1363. PubMed ID: 28423959
[TBL] [Abstract][Full Text] [Related]
19. Transgenerational cycle of obesity and diabetes: investigating possible metabolic precursors in cord blood from the PREOBE study.
Shokry E; Marchioro L; Uhl O; Bermúdez MG; García-Santos JA; Segura MT; Campoy C; Koletzko B
Acta Diabetol; 2019 Sep; 56(9):1073-1082. PubMed ID: 31062097
[TBL] [Abstract][Full Text] [Related]
20. Maternal docosahexaenoic acid supplementation and fetal accretion.
Montgomery C; Speake BK; Cameron A; Sattar N; Weaver LT
Br J Nutr; 2003 Jul; 90(1):135-45. PubMed ID: 12844385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
